paroxetine has been researched along with Coronary Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, SL; Baker, GB; Lara, N; Le Mellédo, JM | 1 |
| Deuschle, M; Gilles, M; Henn, FA; Heuser, I; Kopf, D; Lederbogen, F; Lehnert, H; Luley, CW; Ritter, S; Weber-Hamann, B; Westphal, S | 1 |
| Carson, SW; Davidson, C; Garbutt, JC; Golding, M; Guzzo, J; Hoyler, S; Kotlyar, M; Lazarus, C; Sontz, E | 1 |
| Laghrissi-Thode, F; Pollock, BG; Wagner, WR | 1 |
2 trial(s) available for paroxetine and Coronary Disease
| Article | Year |
|---|---|
Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses.
Topics: Aged; Blood Pressure; Coronary Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Norepinephrine; Paroxetine; Pulse; Stress, Psychological | 2005 |
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; beta-Thromboglobulin; Coronary Disease; Depressive Disorder; Double-Blind Method; Humans; Nortriptyline; Paroxetine; Platelet Activation; Platelet Aggregation; Platelet Factor 4 | 2000 |
2 other study(ies) available for paroxetine and Coronary Disease
| Article | Year |
|---|---|
Increased cholesterol levels during paroxetine administration in healthy men.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Humans; Hypercholesterolemia; Male; Paroxetine; Reference Values; Risk; Selective Serotonin Reuptake Inhibitors; Triglycerides | 2003 |
Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Blood Glucose; Body Mass Index; Cholesterol; Circadian Rhythm; Coronary Disease; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin Resistance; Lipids; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Obesity; Paroxetine; Pituitary-Adrenal System; Risk Factors; Triglycerides | 2004 |